Mennitto A - Search Results

1

Treatment of advanced renal cell carcinoma: recent advances and current role of immunotherapy, surgery, and cryotherapy.

Mennitto A, Verzoni E, Calareso G, Spreafico C, Procopio G. Mennitto A, et al. Tumori. 2017 Jan 21;103(1):15-21. doi: 10.5301/tj.5000581. Epub 2016 Oct 26. Tumori. 2017. PMID: 27791232 Review.

2

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy.

Grassi P, Verzoni E, Ratta R, Mennitto A, de Braud F, Procopio G. Grassi P, et al. Among authors: mennitto a. Drug Des Devel Ther. 2016 Jul 5;10:2167-72. doi: 10.2147/DDDT.S104225. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27462141 Free PMC article. Review.

3

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.

Mennitto A, Grassi P, Ratta R, Verzoni E, Prisciandaro M, Procopio G. Mennitto A, et al. Ther Adv Urol. 2016 Oct;8(5):319-326. doi: 10.1177/1756287216656811. Epub 2016 Jul 7. Ther Adv Urol. 2016. PMID: 27695530 Free PMC article. Review.

4

Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?

Mennitto A, Grassi P, Verzoni E, Ratta R, Procopio G. Mennitto A, et al. J Med Imaging Radiat Oncol. 2017 Apr;61(2):250-251. doi: 10.1111/1754-9485.12575. Epub 2017 Jan 9. J Med Imaging Radiat Oncol. 2017. PMID: 28070961 No abstract available.

5

Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice.

Grassi P, Verzoni E, Mennitto A, Procopio G. Grassi P, et al. Among authors: mennitto a. Transl Androl Urol. 2016 Dec;5(6):974-976. doi: 10.21037/tau.2016.11.06. Transl Androl Urol. 2016. PMID: 28078236 Free PMC article. No abstract available.

6

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.

Pusceddu S, Verzoni E, Prinzi N, Mennitto A, Femia D, Grassi P, Concas L, Vernieri C, Lo Russo G, Procopio G. Pusceddu S, et al. Among authors: mennitto a. Ther Adv Med Oncol. 2017 Mar;9(3):183-188. doi: 10.1177/1758834016683905. Epub 2017 Jan 11. Ther Adv Med Oncol. 2017. PMID: 28344663 Free PMC article. Review.

7

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Grassi P, Verzoni E, Ratta R, Porcu L, Prisciandaro M, Mennitto A, Calareso G, de Braud F, Procopio G. Grassi P, et al. Among authors: mennitto a. Drugs R D. 2017 Sep;17(3):461-467. doi: 10.1007/s40268-017-0203-y. Drugs R D. 2017. PMID: 28801802 Free PMC article.

8

Multimodal treatment of advanced renal cancer in 2017.

Mennitto A, Verzoni E, Grassi P, Ratta R, Fucà G, Procopio G. Mennitto A, et al. Expert Rev Clin Pharmacol. 2017 Dec;10(12):1395-1402. doi: 10.1080/17512433.2017.1386552. Epub 2017 Oct 6. Expert Rev Clin Pharmacol. 2017. PMID: 28956645 Review.

9

Management of Metastatic Collecting Duct Carcinoma: An Encouraging Result in a Patient Treated With Cabozantinib.

Mennitto A, Verzoni E, Peverelli G, Alessi A, Procopio G. Mennitto A, et al. Clin Genitourin Cancer. 2018 Jun;16(3):e521-e523. doi: 10.1016/j.clgc.2018.03.010. Epub 2018 Mar 27. Clin Genitourin Cancer. 2018. PMID: 29656939 No abstract available.

10

Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program.

Prisciandaro M, Ratta R, Massari F, Fornarini G, Caponnetto S, Iacovelli R, De Giorgi U, Facchini G, Scagliarini S, Sabbatini R, Caserta C, Peverelli G, Mennitto A, Verzoni E, Procopio G. Prisciandaro M, et al. Among authors: mennitto a. Am J Clin Oncol. 2019 Jan;42(1):42-45. doi: 10.1097/COC.0000000000000478. Am J Clin Oncol. 2019. PMID: 30204614 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters